CHARGED ALPHA
Stock Detail
CI Unclassified

CI

Live stock metrics, chart context, a quarter-by-quarter episode archive, and a deeper competitor comparison so this page behaves more like an investor workspace than a flat episode link page.

Library coverage

Episodes tracked
1
Episodes linked
1
Latest video
Pending
Podcast available
Yes
Current price
$286.24
+4.05 (+1.44%)
Trailing / Forward P/E
2.52x
Forward: 8.54x
Market cap / Volume
Volume:
Revenue / Earnings Growth
4.6%
Earnings: 29.1%
Margins
5.5% op
Gross: 9.2% · Net: 2.3%
Balance sheet
0.82x current
Debt / Equity: 72.8
52-week range / Beta
$239.51 - $338.89
Beta: 0.31
Analyst target
$341.75
Upside: 19.4%
Cash / shareholder return
9.14% FCF yield
Dividend yield: 2.16%

Company context

Industry: Healthcare Plans
Country: United States
Employees:
Price to book: 1.79x
Return on equity: 16.3%
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Price chart

Market context for CI

Competitive view

CI vs. two close competitors

This section compares the current company against two nearby peers on valuation, growth, margins, balance-sheet strength, and investment setup. Green generally marks the strongest relative figure for that row, while red marks the weakest.

CI
CI
Latest video
YouTube link pending
Growth profile looks strong right now, with above-average top-line and/or earnings momentum.
Cash generation stands out versus market value, which helps the stock absorb valuation pressure better than weaker cash converters.
Valuation looks more grounded than many growth names, which can improve the risk/reward if fundamentals hold up.
Risk profile looks relatively manageable compared with many peers, especially if operating execution remains stable.
SS&C Technologies Holdings Inc.
SSNC
YouTube
Latest video
Q1 2026
Growth is positive but not explosive, which usually supports a steadier compounding case than a hyper-growth story.
Cash generation stands out versus market value, which helps the stock absorb valuation pressure better than weaker cash converters.
Valuation looks more grounded than many growth names, which can improve the risk/reward if fundamentals hold up.
Balance-sheet leverage is elevated, so investors should watch refinancing costs and how much flexibility management really has.
Charles Schwab Corporation
SCHW
YouTube
Latest video
Q1 2026
Growth profile looks strong right now, with above-average top-line and/or earnings momentum.
Profitability is a real strength here, with healthy operating margins helping support resilience through weaker cycles.
Valuation looks more grounded than many growth names, which can improve the risk/reward if fundamentals hold up.
Balance-sheet leverage is elevated, so investors should watch refinancing costs and how much flexibility management really has.
Market Cap
More scale can mean deeper resources and resilience, although bigger does not automatically mean better upside.
CI
$75.72B
CI
SSNC
$16.15B
SS&C Technologies Holdings Inc.
SCHW
$156.78B
Charles Schwab Corporation
Trailing P/E
Lower trailing P/E can indicate a cheaper valuation relative to trailing earnings, but it may also reflect slower growth or higher perceived risk.
CI
2.5x
CI
SSNC
20.8x
SS&C Technologies Holdings Inc.
SCHW
17.9x
Charles Schwab Corporation
Forward P/E
Forward P/E is often a better read on what investors are paying for the next year of earnings power.
CI
8.5x
CI
SSNC
8.9x
SS&C Technologies Holdings Inc.
SCHW
12.5x
Charles Schwab Corporation
Revenue Growth
Higher revenue growth usually signals stronger demand, market share gains, or a business still in expansion mode.
CI
4.6%
CI
SSNC
8.8%
SS&C Technologies Holdings Inc.
SCHW
15.8%
Charles Schwab Corporation
Earnings Growth
Faster earnings growth matters because it shows management is converting sales momentum into shareholder value.
CI
29.1%
CI
SSNC
8.3%
SS&C Technologies Holdings Inc.
SCHW
38.6%
Charles Schwab Corporation
Operating Margin
Higher operating margin suggests better operating discipline, pricing power, or a structurally stronger business model.
CI
5.5%
CI
SSNC
24.2%
SS&C Technologies Holdings Inc.
SCHW
49.4%
Charles Schwab Corporation
Gross Margin
Gross margin helps show how much product-level pricing power and unit economics a company has before overhead.
CI
9.2%
CI
SSNC
48.0%
SS&C Technologies Holdings Inc.
SCHW
97.5%
Charles Schwab Corporation
Net Margin
Higher net margin means more of each dollar of revenue reaches the bottom line after all costs.
CI
2.3%
CI
SSNC
12.7%
SS&C Technologies Holdings Inc.
SCHW
38.0%
Charles Schwab Corporation
Return on Equity
ROE shows how efficiently management turns shareholder capital into profits, though leverage can inflate it.
CI
16.3%
CI
SSNC
11.8%
SS&C Technologies Holdings Inc.
SCHW
19.1%
Charles Schwab Corporation
Free Cash Flow Yield
Higher free cash flow yield can indicate a stronger cash return relative to the stock's market value.
CI
9.1%
CI
SSNC
7.9%
SS&C Technologies Holdings Inc.
SCHW
6.2%
Charles Schwab Corporation
Debt to Equity
Lower leverage usually means less balance-sheet risk, though capital-intensive sectors naturally run higher debt loads.
CI
72.81x
CI
SSNC
110.67x
SS&C Technologies Holdings Inc.
SCHW
120.77x
Charles Schwab Corporation
Current Ratio
A stronger current ratio usually signals better short-term liquidity and more room to absorb shocks.
CI
0.82x
CI
SSNC
1.10x
SS&C Technologies Holdings Inc.
SCHW
0.63x
Charles Schwab Corporation
Beta
Lower beta often means lower volatility versus the market, while higher beta usually brings a rougher ride.
CI
0.31
CI
SSNC
1.12
SS&C Technologies Holdings Inc.
SCHW
0.80
Charles Schwab Corporation
Dividend Yield
Dividend yield matters for income-focused investors, but a high yield can also reflect a stressed stock price.
CI
2.2%
CI
SSNC
1.6%
SS&C Technologies Holdings Inc.
SCHW
1.2%
Charles Schwab Corporation
Analyst Upside
Higher analyst upside suggests the Street still sees room between current price and consensus fair value.
CI
19.4%
CI
SSNC
41.4%
SS&C Technologies Holdings Inc.
SCHW
28.5%
Charles Schwab Corporation

Episode timeline

Episode archive for CI

Each row is one earnings episode with every verified platform link available.

Q1 2026
Episode live
Published podcast complete
CI Stock: Q1 2026 Earnings Analysis
Quarterly earnings-analysis entry for CI. Use the links on the right to open the video or podcast episode.